Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) has been given an average recommendation of “Moderate Buy” by the three ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target […]